FDA decree limits Genzyme drug distribution; WHO scolds EU for customs games delaying Indian drugs;

> Via consent decree, the FDA is restricting Genzyme's U.S. distribution of thyroid cancer drug Thyrogen. FDA Statement

> WHO calls EU on counterfeit/patent gamesmanship in slowing drug shipments from India. Article

> Canadian ointment and creams maker Contract Pharmaceuticals is closing its Buffalo, NY, facility by the end of 2011, eliminating 260 jobs. Article

> Inefficiency and lack of coordination between India's drug-purchasing and drug-manufacturing agencies has led to their merger by Health Minister Maithripala Sirisena. Article

> The Abbott Labs acquisition of India's Piramal Healthcare Solutions will drive more cross-border M&A activity, says ARC Advisory. Post

Suggested Articles

The FDA has found issues with the testing practices of a U.S. generics maker that had specific problems with ADHD and weight-loss drugs.

A warning letter says Chinese API maker Yibin Lihao Bio-technical was found lying to the FDA about manufacturing unapproved heparin.

It took four tries over four years, but Perrigo has finally gotten FDA approval of its generic of Teva’s tricky-to-make ProAir HFA asthma inhaler.